When inter partes review (IPR) proceedings became effective in September 2012, few people would have predicted the transformative effect it would have on patents and the litigation landscape. Three years in, IPR has become...more
9/18/2015
/ America Invents Act ,
Apple ,
Claim Construction ,
Discovery ,
Estoppel ,
Generic Drugs ,
Google ,
Inter Partes Review (IPR) Proceeding ,
Joinder ,
LG Electronics ,
Microsoft ,
Patent Filings ,
Patent Infringement ,
Patent Invalidity ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patent-Eligible Subject Matter ,
Patents ,
Pharmaceutical Patents ,
Prescription Drugs ,
Samsung ,
USPTO
In its first “final” decision under the America Invents Act (AIA), the United States Patent and Trademark Office (USPTO)’s Patent Trial and Appeal Board (PTAB) has invalidated and cancelled all five challenged claims of U.S....more